![]() |
市場調査レポート
商品コード
1576661
持続グルコースモニタリングの市場規模、シェア、予測、動向分析:コンポーネント別(センサー[使い捨て、埋め込み型]、レシーバー、トランスミッター)、年齢層別(大人、子ども)、エンドユーザー別(在宅ケア、病院・クリニック) - 2031年までの世界予測Continuous Glucose Monitoring Market Size, Share, Forecast, and Trends Analysis by Component (Sensors [Disposable, Implantable], Receivers, Transmitters), Age Group (Adults, Children), End User (Homecare, Hospitals & Clinics) - Global Forecast to 2031 |
||||||
カスタマイズ可能
|
持続グルコースモニタリングの市場規模、シェア、予測、動向分析:コンポーネント別(センサー[使い捨て、埋め込み型]、レシーバー、トランスミッター)、年齢層別(大人、子ども)、エンドユーザー別(在宅ケア、病院・クリニック) - 2031年までの世界予測 |
出版日: 2024年09月01日
発行: Meticulous Research
ページ情報: 英文
納期: 5~7営業日
|
世界の持続グルコースモニタリング市場は、2024年から2031年にかけてCAGR15%で、2031年までに314億1,000万米ドルに達すると予測されています。
広範な2次調査と1次調査、市場シナリオの詳細な分析を経て、当レポートは主要な業界促進要因、抑制要因、課題、機会の分析で構成されています。持続グルコースモニタリング(CGM)市場の成長は、糖尿病などの慢性疾患の負担の増加と相まって、人々のライフスタイルの変化、従来のグルコースモニタリングよりもCGMが提供する利点、およびアスリートやフィットネス愛好家によるCGMの使用によって牽引されています。しかし、CGM装置の高コストと製品リコールがこの市場の成長を抑制しています。
さらに、CGMデバイスの技術的進歩、個別化ケアへのシフト、健康意識の高まり、新興国における糖尿病ケアデバイスの利用しやすさの向上は、市場成長の機会を生み出すと予想されます。しかし、糖尿病患者と診断されずに生活している人々の数の多さとCGMデバイスの接着性、信頼性、および精度に関連する問題は、世界の持続グルコースモニタリング市場における主要な課題です。
(注:上位5社のSWOT分析を提供します)
Continuous Glucose Monitoring Market Size, Share, Forecast, and Trends Analysis by Component (Sensors [Disposable, Implantable], Receivers, Transmitters), Age Group (Adults, Children), End User (Homecare, Hospitals & Clinics)-Global Forecast to 2031
The global continuous glucose monitoring market is projected to reach $31.41 billion by 2031 at a CAGR of 15% from 2024 to 2031.
Succeeding extensive secondary and primary research and in-depth analysis of the market scenario, the report comprises the analysis of key industry drivers, restraints, challenges, and opportunities. The growth of the continuous glucose monitoring (CGM) market is driven by lifestyle changes among the population coupled with the growing burden of chronic conditions such as diabetes, the benefits offered by CGM over conventional glucose monitoring, and the use of CGM by athletes and fitness enthusiasts. However, high costs and product recalls of CGM devices restrain the growth of this market.
Furthermore, technological advancements in CGM devices, a shift toward personalized care and, rising health awareness, and increasing accessibility for diabetes care devices in developing countries are expected to generate market growth opportunities. However, the high number of people living undiagnosed with diabetes patients and problems related to the adhesiveness, reliability, and accuracy of CGM devices are major challenges in the global continuous glucose monitoring market.
The report offers a competitive landscape based on an extensive assessment of the product portfolio offerings, geographic presences, and key strategic developments adopted by leading market players in the industry in the past three to four years. The key players operating in the continuous glucose monitoring market are DexCom, Inc. (US), Abbott Laboratories (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Medtronic plc (Ireland), Nemaura Medical Inc. (UK), LifeScan, Inc. (US), Senseonics Holdings, Inc. (U.S.), A. Menarini Diagnostics S.r.l (Italy), Medtrum. Technologies, Inc. (Shanghai.), and B. Braun SE (Germany).
Among all the components studied in this report, in 2024, the sensors segment is expected to account for the largest share of 52.4% of the continuous glucose monitoring market. The sensors segment is further segmented into disposable sensors and implantable sensors. The large market segment is attributed to the high demand for continuous glucose monitoring and frequent purchases of sensors compared to receivers and transmitters. Sensors require more frequent replacement compared to other components. Disposable sensors are replaced in 7 to 14 days after placement while implantable sensors can be replaced in 150-180 days.
Among all the age groups studied in this report, in 2024, the adult segment is expected to account for a larger share of the continuous glucose monitoring market. This segment's large market share can be attributed to the high proportion of the geriatric population with diabetes and changing lifestyles leading to diseases such as obesity, depression, anxiety, and cardiovascular diseases.
Among all the end users studied in this report, in 2024, the home care settings segment is expected to account for a larger share of 82.3% of the continuous glucose monitoring market. The large market share of this segment is attributed to factors such as the high prevalence of diabetes worldwide, rising awareness among people, a shift toward preventive healthcare, and easy accessibility to CGM in developed countries. CGM technologies provide numerous advantages in home care settings. There is a growing shift toward home healthcare due to the lack of healthcare professionals and increasing consumer awareness regarding the monitoring of diabetic conditions through CGM, which supports the large market share of the segment.
An in-depth analysis of the geographical scenario of the global continuous glucose monitoring market provides detailed qualitative and quantitative insights into the five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) along with the coverage of major countries in each region. Asia-Pacific is projected to register the highest CAGR of 17.4% during the forecast period. The market growth of this region is attributed to the advancing healthcare infrastructure, growing disposable income, and rising investments by major key market players. Furthermore, economic growth, as well as technological developments support the market growth in Asia-Pacific.
Continuous glucose monitoring Market Assessment-by Component
Continuous glucose monitoring Market Assessment-by Age Group
Continuous glucose monitoring Market Assessment-by End User
Continuous glucose monitoring Market Assessment-by Geography
(Note: SWOT Analysis will be Provided for The Top 5 Players)